Wen Li

机构：Second Affiliated Hospital of Zhejiang University · ORCID：0000-0002-8981-8380

发表论文 157 篇 · 总被引 4080 次 · h-index 31

代表论文

• Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches (2025 · Nature Reviews Clinical Oncology · 被引 34)
• Global burden and characterization of hypertriglyceridemia-induced acute pancreatitis: results from a systematic review and a multi-center cohort study (2025 · Science China Life Sciences · 被引 17)
• The role and clinical significance of myeloperoxidase (MPO) and TNF-α in prognostic evaluation of T-COPD (2025 · BMC Pulmonary Medicine · 被引 9)
• First-line serplulimab plus chemotherapy with or without HLX04 versus chemotherapy in locally advanced or metastatic non-squamous non-small-cell lung cancer (ASTRUM-002): a randomised, double-blind, multicentre phase 3 trial (2025 · The Lancet Respiratory Medicine · 被引 7)
• Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alteration (2025 · Cancer Biology and Medicine · 被引 7)
• Successful aging rates of global older adults: A subgroup meta-analysis (2025 · Archives of Gerontology and Geriatrics · 被引 5)